Stocks · Health care · Pharmaceutical Preparations

Abbott Laboratories

ABT Clue Score62
United States Fiscal year ends December CIK 0000001800 Results filed 21 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
John G Stratton
7 May 2026
Director
Buy
2,000
$86.82
$173.64K
Daniel J Starks
27 Apr 2026
Director
Buy
10,000
$92.65
$926.54K
Philip P Boudreau
23 Apr 2026
EVP and CFO
Buy indirect
2,200
$91.50
$201.30K
Daniel J Starks
4 Feb 2026
Director
Buy
5,033
$108.33
$545.24K
Daniel J Starks
4 Feb 2026
Director
Buy
4,967
$109.14
$542.09K
Robert B Ford
23 Jan 2026
Chairman and CEO
Buy indirect
18,800
$107.13
$2.01M
Michelle Kumbier
23 Feb 2021
Director
Buy
2,040
$122.50
$249.90K
Randel William Woodgrift
22 Apr 2019
Senior Vice President
Buy
2,000
$73.40
$146.80K
Showing 250 of 1,360 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 916
Amendments (4/A) skipped 6
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 384
Sales at will 719
Transactions with no price 0
Shares from compensation/vesting 17,573,242
Sales filed before the plan box existed 692
History held since 3 Oct 2006